Cat# | Product Name | Cas# | Standard |
ZTM | 4-[[(4-Fluorophenyl)imino]methyl]-phenol | 3382-63-6 | In-House |
ZT-4 | (S)-1-(4-fluorophenyl)-5- (2-oxo-4-phenyloxazolidin-3-yl) pentane-1,5-dione | 189028-93-1 | In-House |
ZT-5 | (S)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one | 189028-95-3 | In-House |
ZT-6 | (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl] -4-phenyl-1,3-oxazolidin-2-one | 272778-12-8 | In-House |
ZTB-4 | Methyl (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoate | 204589-80-0 | In-House |
ZTB-8 | (3R,4S)-4-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)azetidi | 163222-32-0 | In-House |
ZT | Ezetimibe | 163222-33-1 | In-House |
801# Changwu Middle Road, Wujin District, Changzhou, 213164,
China
Tel: +86 519 69697536
Fax: +86 519 89889226
info@changjunpharma.com
sean.kwok@changjunpharma.com
Official WeChat